Ingevity Corporation
NGVTNYSEBasic Materials● Active
$65.99
$-0.10(-0.15%)
Market Cap$2.3B
P/E Ratio—
52W High$79.29
52W Low$39.74
Ingevity Corporation (NGVT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NGVT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$1.15
Est. $0.84 · +36.9%
Revenue
$0.26B
Est. $0.25B · +1.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
NGVT reports quarterly as a NYSE-listed Chemicals - Specialty company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | $1.31 | — | — | — | $0.30B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $0.84 | $1.15 | +36.9% | $0.26B | $0.25B | +1.3% |
| ▼ Q1 FY2026 | Feb 25, 2026 | $0.67 | $0.58 | -12.8% | $0.26B | $0.26B | -0.8% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.68 | $1.31 | +92.7% | $0.33B | $0.26B | +29.5% |
| ▲ Q3 FY2025 | Aug 4, 2025 | $1.02 | $1.39 | +36.3% | $0.37B | $0.37B | -1.9% |
| ▲ Q2 FY2025 | May 5, 2025 | $0.74 | $0.99 | +33.8% | $0.28B | $0.29B | -0.5% |
| ▲ Q1 FY2025 | Feb 18, 2025 | $0.29 | $0.95 | +227.6% | $0.30B | $0.33B | -9.0% |
| ▲ Q4 FY2024 | Oct 29, 2024 | $0.60 | $1.10 | +83.3% | $0.38B | $0.31B | +21.3% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
$1.31
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$1.15
EPS Est.
$0.84
EPS Surpr.
+36.9%
Revenue
$0.26B
Q1 FY2026
Feb 25, 2026Miss
EPS Actual
$0.58
EPS Est.
$0.67
EPS Surpr.
-12.8%
Revenue
$0.26B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$1.31
EPS Est.
$0.68
EPS Surpr.
+92.7%
Revenue
$0.33B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$1.39
EPS Est.
$1.02
EPS Surpr.
+36.3%
Revenue
$0.37B
Q2 FY2025
May 5, 2025Beat
EPS Actual
$0.99
EPS Est.
$0.74
EPS Surpr.
+33.8%
Revenue
$0.28B
Q1 FY2025
Feb 18, 2025Beat
EPS Actual
$0.95
EPS Est.
$0.29
EPS Surpr.
+227.6%
Revenue
$0.30B
Q4 FY2024
Oct 29, 2024Beat
EPS Actual
$1.10
EPS Est.
$0.60
EPS Surpr.
+83.3%
Revenue
$0.38B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.30 | $1.35 | $1.40 | 1 |
| Q3 FY2028 | $1.93 | $2.01 | $2.09 | 1 |
| Q2 FY2028 | $2.07 | $2.16 | $2.24 | 1 |
| Q1 FY2028 | $1.48 | $1.54 | $1.60 | 1 |
| Q4 FY2027 | $1.04 | $1.08 | $1.13 | 1 |
| Q3 FY2027 | $1.65 | $1.71 | $1.78 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.3B | 1 |
| Q3 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +36.9% | $77.10 | $77.87 | +1.00% |
| ▼ Q1 FY2026 | Feb 25, 2026 | -12.8% | $71.12 | $69.60 | -2.14% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +92.7% | $52.58 | $54.46 | +3.58% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +36.3% | $40.40 | $40.85 | +1.11% |
| ▲ Q2 FY2025 | May 5, 2025 | +33.8% | $35.04 | $35.52 | +1.37% |
| ▲ Q1 FY2025 | Feb 18, 2025 | +227.6% | $45.10 | $45.84 | +1.64% |
| ▲ Q4 FY2024 | Oct 29, 2024 | +83.3% | $35.74 | $35.32 | -1.18% |
| ▼ Q3 FY2024 | Jul 31, 2024 | -3.8% | $46.11 | $45.89 | -0.48% |
Q2 FY2026+1.00%
Report Date
May 6, 2026
EPS Beat/Miss
+36.9%
Price Before
$77.10
Price After
$77.87
Q1 FY2026-2.14%
Report Date
Feb 25, 2026
EPS Beat/Miss
-12.8%
Price Before
$71.12
Price After
$69.60
Q4 FY2025+3.58%
Report Date
Nov 5, 2025
EPS Beat/Miss
+92.7%
Price Before
$52.58
Price After
$54.46
Q3 FY2025+1.11%
Report Date
Aug 4, 2025
EPS Beat/Miss
+36.3%
Price Before
$40.40
Price After
$40.85
Q2 FY2025+1.37%
Report Date
May 5, 2025
EPS Beat/Miss
+33.8%
Price Before
$35.04
Price After
$35.52
Q1 FY2025+1.64%
Report Date
Feb 18, 2025
EPS Beat/Miss
+227.6%
Price Before
$45.10
Price After
$45.84
Q4 FY2024-1.18%
Report Date
Oct 29, 2024
EPS Beat/Miss
+83.3%
Price Before
$35.74
Price After
$35.32
Q3 FY2024-0.48%
Report Date
Jul 31, 2024
EPS Beat/Miss
-3.8%
Price Before
$46.11
Price After
$45.89
Avg Beat Reaction+1.25%
Avg Miss Reaction-1.31%
Beat Rate6 / 8 quarters
Largest Move+3.58% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NGVT ends December
Ingevity Corporation (NGVT) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $1.15 — beating the analyst consensus of $0.84 by +36.9%. The next NGVT earnings date is expected around September 1, 2026.
Each quarter, investors track NGVT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NGVT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NGVT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NGVT earnings · 5 questionsIngevity Corporation's next earnings report is expected around September 1, 2026. NGVT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NGVT historically reports after market close (AMC).
NGVT earnings datewhen is NGVT earningsNGVT next earnings datewhen does NGVT report earningsNGVT earnings calendar
▸ Source: FMP · Ingevity Corporation SEC filings · US GAAP · Ingevity Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026